Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Starlinger

Showing results (21-30 of 140) with videos related to

Pageof 14
Sort By:
International Journal of Molecular Sciences|April 3, 2021
Till Death Do Us Part-The Multifaceted Role of Platelets in Liver DiseasesMarion Mussbacher, Laura Brunnthaler, Anja Panhuber, et al.
Gastro Hep Advances|June 9, 2025
Risk Factors for Incidental Gallbladder Cancer Found During Cholecystectomy for Cholelithiasis: A Case-Control StudyChristina Liava, Patrick Starlinger, Patrick S Kamath, et al.
Hepatology (Baltimore, Md.)|October 22, 2014
Reply: To PMID 24277679Patrick Starlinger, Mickael Lesurtel, Christine Brostjan, et al.
Hepatology Communications|September 10, 2019
<i>PNPLA3</i> I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate CellsFrancesca Virginia Bruschi, Thierry Claudel, Matteo Tardelli, et al.
Biomarkers in Medicine|June 17, 2015
Erratum. Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancerAysegül Ilhan-Mutlu, Patrick Starlinger, Thomas Perkmann, et al.
Biomarkers in Medicine|March 27, 2015
Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancerAysegül Ilhan-Mutlu, Patrick Starlinger, Thomas Perkmann, et al.
Annals of Surgical Oncology|October 18, 2014
CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastasesStefan Stremitzer, Judith Stift, Alexandra Graf, et al.
Plos One|April 14, 2017
Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activityDavid Pereyra, Florian Offensperger, Florian Klinglmueller, et al.
Pleura and Peritoneum|September 4, 2023
Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Akash Kartik, Catharina Müller, Miklos Acs, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Liver Metastasectomy in Anal Squamous Cell Carcinoma: The Mayo Clinic ExperienceNoah Takacs, Conor D J O'Donnell, Nguyen Tran, et al.
Pageof 14

Showing results (21-30 of 140) with videos related to

Sort By:
Pageof 14
International Journal of Molecular Sciences|April 3, 2021
Till Death Do Us Part-The Multifaceted Role of Platelets in Liver DiseasesMarion Mussbacher, Laura Brunnthaler, Anja Panhuber, et al.
Gastro Hep Advances|June 9, 2025
Risk Factors for Incidental Gallbladder Cancer Found During Cholecystectomy for Cholelithiasis: A Case-Control StudyChristina Liava, Patrick Starlinger, Patrick S Kamath, et al.
Hepatology (Baltimore, Md.)|October 22, 2014
Reply: To PMID 24277679Patrick Starlinger, Mickael Lesurtel, Christine Brostjan, et al.
Hepatology Communications|September 10, 2019
<i>PNPLA3</i> I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate CellsFrancesca Virginia Bruschi, Thierry Claudel, Matteo Tardelli, et al.
Biomarkers in Medicine|June 17, 2015
Erratum. Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancerAysegül Ilhan-Mutlu, Patrick Starlinger, Thomas Perkmann, et al.
Biomarkers in Medicine|March 27, 2015
Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancerAysegül Ilhan-Mutlu, Patrick Starlinger, Thomas Perkmann, et al.
Annals of Surgical Oncology|October 18, 2014
CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastasesStefan Stremitzer, Judith Stift, Alexandra Graf, et al.
Plos One|April 14, 2017
Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activityDavid Pereyra, Florian Offensperger, Florian Klinglmueller, et al.
Pleura and Peritoneum|September 4, 2023
Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Akash Kartik, Catharina Müller, Miklos Acs, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Liver Metastasectomy in Anal Squamous Cell Carcinoma: The Mayo Clinic ExperienceNoah Takacs, Conor D J O'Donnell, Nguyen Tran, et al.
Pageof 14